Savior Lifetec Corporation (4167.TWO)
TWD 17.65
(-9.95%)
TWD 17.65
(-9.95%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.05 Billion TWD | -17.02% |
| 2022 | 1.26 Billion TWD | -27.41% |
| 2021 | 1.74 Billion TWD | -4.57% |
| 2020 | 1.82 Billion TWD | 38.56% |
| 2019 | 1.31 Billion TWD | 19.37% |
| 2018 | 1.1 Billion TWD | -31.73% |
| 2017 | 1.61 Billion TWD | 5.61% |
| 2016 | 1.53 Billion TWD | 36.72% |
| 2015 | 1.12 Billion TWD | 9.99% |
| 2014 | 1.01 Billion TWD | 1.82% |
| 2013 | 1 Billion TWD | 19.43% |
| 2012 | 837.81 Million TWD | 6.55% |
| 2011 | 786.33 Million TWD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 348.73 Million TWD | 34.55% |
| 2024 Q1 | 259.19 Million TWD | -18.49% |
| 2023 Q3 | 287.22 Million TWD | 28.7% |
| 2023 Q4 | 317.98 Million TWD | 10.71% |
| 2023 FY | 1.05 Billion TWD | -17.02% |
| 2023 Q1 | 221.89 Million TWD | -12.7% |
| 2023 Q2 | 223.17 Million TWD | 0.58% |
| 2022 FY | 1.26 Billion TWD | -27.41% |
| 2022 Q4 | 254.17 Million TWD | -26.98% |
| 2022 Q2 | 356.14 Million TWD | 15.88% |
| 2022 Q3 | 348.09 Million TWD | -2.26% |
| 2022 Q1 | 307.33 Million TWD | -8.31% |
| 2021 Q3 | 379.04 Million TWD | -27.61% |
| 2021 Q1 | 505.94 Million TWD | -10.77% |
| 2021 FY | 1.74 Billion TWD | -4.57% |
| 2021 Q2 | 523.59 Million TWD | 3.49% |
| 2021 Q4 | 335.19 Million TWD | -11.57% |
| 2020 FY | 1.82 Billion TWD | 38.56% |
| 2020 Q3 | 429.31 Million TWD | 6.82% |
| 2020 Q2 | 401.91 Million TWD | -6.31% |
| 2020 Q1 | 428.98 Million TWD | 14.21% |
| 2020 Q4 | 567.01 Million TWD | 32.07% |
| 2019 Q2 | 304.22 Million TWD | 2.3% |
| 2019 Q4 | 375.62 Million TWD | 10.0% |
| 2019 Q3 | 341.46 Million TWD | 12.24% |
| 2019 FY | 1.31 Billion TWD | 19.37% |
| 2019 Q1 | 297.37 Million TWD | 18.71% |
| 2018 FY | 1.1 Billion TWD | -31.73% |
| 2018 Q4 | 250.5 Million TWD | -3.91% |
| 2018 Q3 | 260.68 Million TWD | -16.81% |
| 2018 Q2 | 313.36 Million TWD | 11.86% |
| 2018 Q1 | 280.14 Million TWD | -12.27% |
| 2017 FY | 1.61 Billion TWD | 5.61% |
| 2017 Q3 | 388.85 Million TWD | -12.45% |
| 2017 Q1 | 465.8 Million TWD | -3.33% |
| 2017 Q2 | 444.15 Million TWD | -4.65% |
| 2017 Q4 | 319.3 Million TWD | -17.89% |
| 2016 Q4 | 481.87 Million TWD | 17.85% |
| 2016 FY | 1.53 Billion TWD | 36.72% |
| 2016 Q1 | 293.87 Million TWD | 16.22% |
| 2016 Q3 | 408.89 Million TWD | 17.66% |
| 2016 Q2 | 347.5 Million TWD | 18.25% |
| 2015 Q4 | 252.87 Million TWD | -12.89% |
| 2015 Q3 | 290.29 Million TWD | 0.29% |
| 2015 FY | 1.12 Billion TWD | 9.99% |
| 2015 Q2 | 289.46 Million TWD | 0.52% |
| 2015 Q1 | 287.97 Million TWD | -11.91% |
| 2014 Q3 | 214.82 Million TWD | -14.57% |
| 2014 FY | 1.01 Billion TWD | 1.82% |
| 2014 Q4 | 326.91 Million TWD | 52.18% |
| 2014 Q2 | 251.44 Million TWD | 11.45% |
| 2014 Q1 | 225.61 Million TWD | -6.6% |
| 2013 Q1 | 258.29 Million TWD | 7.31% |
| 2013 Q4 | 241.55 Million TWD | -0.38% |
| 2013 FY | 1 Billion TWD | 19.43% |
| 2013 Q3 | 242.48 Million TWD | -6.12% |
| 2013 Q2 | 258.29 Million TWD | 0.0% |
| 2012 Q2 | - TWD | 0.0% |
| 2012 FY | 837.81 Million TWD | 6.55% |
| 2012 Q4 | 240.7 Million TWD | 0.0% |
| 2012 Q3 | 240.7 Million TWD | 0.0% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 FY | 786.33 Million TWD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -144168.819% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 5.778% |
| Level Biotechnology Inc. | 660.61 Million TWD | -58.986% |
| Sagittarius Life Science Corp | 440.46 Million TWD | -138.45% |
| NeoCore Technology Co., Ltd. | 64.72 Million TWD | -1522.576% |
| TaiMed Biologics Inc. | 491.77 Million TWD | -113.568% |
| GlycoNex Incorporation | 2.54 Million TWD | -41216.955% |
| VBI | 55.85 Million TWD | -1780.431% |
| GeneReach Biotechnology Corp. | 225.46 Million TWD | -365.837% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | -232.383% |
| SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | -5100.421% |
| Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | -165.126% |
| Visgeneer Inc. | 147.99 Million TWD | -609.675% |
| Mycenax Biotech Inc. | 652.62 Million TWD | -60.932% |
| Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 37.816% |
| G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | -478.847% |
| Neith Corporation | 39.9 Million TWD | -2532.075% |
| Medigen Vaccine Biologics Corporation | 389.62 Million TWD | -169.562% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -4518.226% |
| Enimmune corporation | 43.49 Million TWD | -2314.763% |
| TaiRx, Inc. | 5.08 Million TWD | -20566.608% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| EirGenix Inc. | 1.02 Billion TWD | -2.701% |
| BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | -296.746% |
| Sunny Pharmtech Inc. | 428.82 Million TWD | -144.919% |
| Lin BioScience, Inc. | - TWD | -Infinity% |
| BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | -855.596% |
| Feng Chi Biotech Corp. | 180.57 Million TWD | -481.62% |
| Bio Preventive Medicine Corp. | 1.2 Million TWD | -86843.46% |
| Lukas Biomedical Inc. | 231.83 Million TWD | -353.032% |
| RBC Bioscience Corporation | 172.46 Million TWD | -508.973% |
| BiOptic Inc. | 228.26 Million TWD | -360.105% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -1166874.444% |
| Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -10927.688% |
| Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -21555.196% |
| Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 42.832% |
| Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
| NaviFUS Corp. | 22.48 Million TWD | -4571.843% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | -643.949% |
| Sinew Pharma Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -130369.193% |
| Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | -31.201% |
| Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | -1745.311% |
| AP Biosciences Inc | 32.25 Million TWD | -3156.37% |
| Medigen Biotechnology Corp. | 1.15 Billion TWD | 9.281% |
| 3D Global Biotech Inc. | 20.63 Million TWD | -4990.278% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | -233.951% |
| Intech Biopharm Corporation | 25.84 Million TWD | -3963.439% |
| Oneness Biotech Co., Ltd. | 86.78 Million TWD | -1110.234% |
| Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
| TWi Biotechnology, Inc. | - TWD | -Infinity% |
| Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | -38.488% |
| TCI GENE Inc. | 333.85 Million TWD | -214.591% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -5834772.222% |
| Senhwa Biosciences, Inc. | 1 Million TWD | -104927.7% |
| Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | -1128.825% |
| NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | -555.841% |
| PharmaEngine, Inc. | 767.66 Million TWD | -36.814% |
| TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | -752.955% |
| OBI Pharma, Inc. | 41.54 Million TWD | -2427.803% |
| Meribank Biotech Co., Ltd | 234.34 Million TWD | -348.181% |
| Acepodia, Inc. | 16.59 Million TWD | -6229.639% |
| Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | -2597.722% |